Search

Your search keyword '"A Bayes Genis"' showing total 9,701 results

Search Constraints

Start Over You searched for: "A Bayes Genis" Remove constraint "A Bayes Genis"
9,701 results on '"A Bayes Genis"'

Search Results

51. Biomarkers for the Diagnosis of Heart Failure in People with Diabetes: A Consensus Report from Diabetes Technology Society

57. Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society

59. New Findings on Type 2 Diabetes from Antoni Bayes-Genis and Co-Authors Summarized (Renal function dynamics following co-administration of sacubitril/valsartan and empagliflozin in patients with heart failure and type 2 diabetes)

60. Quality of life in patients with heart failure and improved ejection fraction: one‐year changes and prognosis

66. Infective endocarditis in adult patients with congenital heart disease

67. Impact analysis of heart failure across European countries: an ESC‐HFA position paper

68. Circulating levels and prognostic cut‐offs of sST2, hs‐cTnT, and NT‐proBNP in women vs. men with chronic heart failure

69. Sacubitril/valsartan affects pulmonary arterial pressure in heart failure with preserved ejection fraction and pulmonary hypertension

72. Right heart failure with left ventricular assist devices: Preoperative, perioperative and postoperative management strategies. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC

73. Percutaneous repair of moderate‐to‐severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE‐HF2 trial and comparison to COAPT and MITRA‐FR trials

74. Differences in presentation, diagnosis and management of heart failure in women. A scientific statement of the Heart Failure Association of the ESC

75. How to tackle therapeutic inertia in heart failure with reduced ejection fraction. A scientific statement of the Heart Failure Association of the ESC

79. Personalized assessment of the cumulative complication risk of the atrial fibrillation ablation track: The AF-TRACK calculator

82. Circulating virome and inflammatory proteome in patients with ST-elevation myocardial infarction and primary ventricular fibrillation

83. Prevention and Rehabilitation After Heart Transplantation: A Clinical Consensus Statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a Section of ESOT

84. Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights From the EMPACT-MI Trial.

86. Clinical Risk Score to Predict Pathogenic Genotypes in Patients With Dilated Cardiomyopathy

89. Finding a reliable assay for soluble neprilysin

94. Cardiac protection by pirfenidone after myocardial infarction: a bioinformatic analysis

95. Punto de corte óptimo del antígeno carbohidrato 125 para la identificación de pacientes con bajo riesgo tras un ingreso por insuficiencia cardiaca aguda

96. The multidimensional value of natriuretic peptides in heart failure, integrating laboratory and clinical aspects.

97. Physician‐directed patient self‐management in heart failure using left atrial pressure: Interim insights from the VECTOR‐HF I and IIa studies.

100. Bone marrow endothelial dysfunction promotes myeloid cell expansion in cardiovascular disease

Catalog

Books, media, physical & digital resources